MK0826, ertapenem sodium / Duration of Treatment: 14 Days

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

InfectionPneumoniaSepsisUrinary Tract Infection

Phase 3

To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)

CompletedNCT00398099

Merck Sharp & Dohme LLCInfection, Pneumonia, Urinary Tract Infection

Start: 2005-07-31End: 2006-01-31Target: 30Updated: 2017-02-17

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

CompletedNCT00397956

Merck Sharp & Dohme LLCSepsis

Start: 2004-09-30End: 2005-12-31Target: 30Updated: 2015-10-30